Innovations in subcutaneous infusions.
J Infus Nurs
; 38(3): 179-87, 2015.
Article
en En
| MEDLINE
| ID: mdl-25871865
Parenteral drug delivery is an essential part of patient care. The subcutaneous (SC) route is easily accessed, is more cost-effective, and provides increased convenience for the patient than the other parenteral methods. The pharmacokinetic profile of medications delivered SC reflect bioavailabilities similar to intravenous (IV) delivery. The coadministration of human recombinant hyaluronidase with SC medications enhances the maximum concentration and time to maximum concentration to more closely mimic drugs delivered by the IV route. Pharmaceutical companies are studying and successfully developing new formulations of current medications for delivery via the SC route.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Infusiones Subcutáneas
/
Hialuronoglucosaminidasa
Tipo de estudio:
Sysrev_observational_studies
Límite:
Humans
Idioma:
En
Revista:
J Infus Nurs
Asunto de la revista:
ENFERMAGEM
Año:
2015
Tipo del documento:
Article
Pais de publicación:
Estados Unidos